Article Information
History
- March 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Aisha D. Fakhroo1,
- Gheyath K. Nasarallah2,3,*,
- Taushif Khan4,
- Farhan S. Cyprian5,
- Fatima Al Ali4,
- Manar M.A. Ata4,
- Sara Taleb6,
- Ali A. Hssain7,
- Ali H. Eid8,
- Laith J. Abu-Raddad9,
- Abdullatif Al-Khal7,
- Asmaa A. Al Thani2,3,
- Nico Marr10 and
- Hadi M. Yassine2,3,*
- 1Research and Development Department, Barzan Holdings, Doha, Qatar
- 2Biomedical Research Center, Qatar University, Doha, Qatar
- 3Department of Biomedical Sciences, College of Health Sciences-QU health, Qatar University, Doha, Qatar
- 4Research Branch, Sidra Medicine, Doha, Qatar
- 5Basic Medical Science Department, College of Medicine-QU Health, Qatar University, Doha Qatar
- 6Genomics and Precision Medicine, Hamad Bin Khalifa University, Doha, Qatar
- 7Hamad Medical Corporation, Doha, Qatar
- 8Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
- 9Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
- 10College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar
- ↵*Corresponding authors: Gheyath.nasrallah{at}qu.edu.qa, hyassine{at}qu.edu.qa
Posted March 10, 2021.
Detection of autoimmune antibodies in severe but not in moderate or asymptomatic COVID-19 patients
